Female neurogenic vesicourethral dysfunction: evaluation and management.
This paper outlines the evaluation and management of neurogenic vesicourethral dysfunction (NVUD). The anatomy and neurophysiology involved with lower urinary tract functions are reviewed. Multiple sclerosis, diabetes, lumbar disc prolapse, and Parkinson's disease are specifically addressed. Proper evaluation of patients suspected of having NVUD, which is fundamental to making an accurate diagnosis, is discussed. This is followed by options for initiating individualized management plans that focus on protecting and preserving renal function, in addition to relieving the symptoms of NVUD.
McCrery
Rebecca J
RJ
Scott Department of Urology, Baylor College of Medicine, 6550 Fannin Avenue, Suite 801, Houston, TX 77030, USA. rmccrery@bcm.tmc.edu
Appell
Rodney A
RA
D001521:Behavior Therapy; D004599:Electric Stimulation Therapy; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D001743:Urinary Bladder / Q000503:physiopathology; D001750:Urinary Bladder, Neurogenic / Q000503:physiopathology / Q000628:therapy; D014563:Urodynamics / Q000502:physiology*
D009465:Neuromuscular Agents